AU2012254881B2 - Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases - Google Patents

Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases Download PDF

Info

Publication number
AU2012254881B2
AU2012254881B2 AU2012254881A AU2012254881A AU2012254881B2 AU 2012254881 B2 AU2012254881 B2 AU 2012254881B2 AU 2012254881 A AU2012254881 A AU 2012254881A AU 2012254881 A AU2012254881 A AU 2012254881A AU 2012254881 B2 AU2012254881 B2 AU 2012254881B2
Authority
AU
Australia
Prior art keywords
method
administered
dione
amino
mg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012254881A
Other versions
AU2012254881A1 (en
Inventor
Jerome B. Zeldis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Corp
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US60/380,842 priority Critical
Priority to US60/424,600 priority
Priority to AU2010201484A priority patent/AU2010201484B2/en
Application filed by Celgene Corp filed Critical Celgene Corp
Priority to AU2012254881A priority patent/AU2012254881B2/en
Publication of AU2012254881A1 publication Critical patent/AU2012254881A1/en
Application granted granted Critical
Publication of AU2012254881B2 publication Critical patent/AU2012254881B2/en
Priority claimed from AU2013263799A external-priority patent/AU2013263799B2/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links